Our take on the latest news and views on data.

Relevant company news, articles, podcasts, and blog posts.

Recent Posts

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Recent Tweets

$LLY Lilly to share Phase 3 EMBER-3 study results of Imlunestrant, an oral SERD, and more breast cancer portfolio findings at San Antonio Breast Cancer Symposium.

More Info: https://pryzm.ozmosi.com/product/21349 $XBI $IBB $XPH $PPH

$OKUR OnKure will share clinical and preclinical data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium.

More Info: https://pryzm.ozmosi.com/product/32458 $XBI $IBB $XPH $PPH

$IRON Disc Medicine will host a conference call to discuss the End of Phase 2 FDA meeting for Bitopertin in Erythropoietic Protoporphyria (EPP).

More Info: https://pryzm.ozmosi.com/product/269 $XBI $IBB $XPH $PPH

$ADTX, APLIF, EVFM, TSX:APLI Aditxt's Target Acquisition Appili Therapeutics aligns with FDA on ATI-1801 topical antiparasitic NDA submission requirements.

More Info: https://pryzm.ozmosi.com/product/30228 $XBI $IBB $XPH $PPH

Load More

Get Started with OZMOSI

We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.

600 Warren Ave,
Spring Lake, NJ 07762